| Literature DB >> 34306707 |
Dallis Ngo1, Ghulam Aftab1, Arjun Madhavan1, Amar Bukhari1.
Abstract
Pulmonary vein thrombosis (PVT) is a rare clinical finding that is potentially fatal and with an unknown incidence rate as known cases exist predominantly in case reports. We present the case of a 58-year-old female who reported sudden onset of chest pain, shortness of breath, and dyspnoea on exertion. A computed tomography (CT) pulmonary angiogram was negative for evidence of pulmonary embolism; however, it did demonstrate the evidence of thrombosis of the right lower lobe segmental pulmonary vein. She had no identifiable aetiologies for her PVT; therefore, she was diagnosed with idiopathic PVT and was treated successfully with apixaban. This case represents the 14th incidence of idiopathic PVT in the current body of medical literature and the first case of successful treatment with apixaban.Entities:
Keywords: Apixaban; breast cancer; idiopathic; pulmonary vein thrombosis; venous thrombosis
Year: 2021 PMID: 34306707 PMCID: PMC8292945 DOI: 10.1002/rcr2.803
Source DB: PubMed Journal: Respirol Case Rep ISSN: 2051-3380
Figure 1Axial view of a computed tomography (CT) pulmonary angiogram demonstrating a pulmonary vein thrombus (red arrow) involving the right lower lobe segmental vein.
Idiopathic PVT cases reported in the current literature.
| Author | Age and gender | Comorbidities | Clinical presentation | Method of diagnosis and result | Additional workup | Treatment |
|---|---|---|---|---|---|---|
| Selvidge and Gavant, 1999 [ | 33 F | Sickle cell trait, tobacco smoker, cocaine | Acute onset left‐sided abdominal pain, nausea, and vomiting | CT abdomen with contrast: irregular, small areas of non‐enhancing infarction within the spleen and a 2‐cm diameter filling the defect in the left atrium extending from a thrombus in the distal right lower pulmonary vein |
CXR: patchy opacity in the right lower lobe TTE: normal findings ECG‐gated MRI: bland thrombosis of the right lower pulmonary vein with extension into the left atrium | Oral anticoagulant |
| Alexander et al., 2009 [ | 47 F | None | Massive haemoptysis, left chest pain, dyspnoea | Pathology of the left lower lobectomy: sections of the lung parenchyma demonstrated red hepatization with thrombosis of the pulmonary venous system | TTE: no evidence of thrombosis in the left atrium | Surgical resection of the affected lobe and thrombectomy |
| Komatsu et al., 2011 [ | 57 M | Hyperlipidaemia | Chest pain with myocardial infarction | CT chest: bilateral lower pulmonary vein thrombus | Warfarin. Antiplatelet for CAD | |
| Mumoli and Cei, 2012 [ | 80 M | Coronary artery disease s/p CABG, congestive heart failure | Acute shortness of breath | CT chest: bilateral pleural effusions and a large thrombus in the left superior pulmonary vein |
CXR: near‐round opacity in the upper left lobe with fissure involvement TTE: ejection fraction 30% Hypercoagulable workup: normal except homocysteine of 18.5 μmol/L | Enoxaparin bridged to warfarin |
| Takeuchi, 2012 [ | 79 M | Hypertension | Chest pain | 64‐MDCT: 17.2 × 1.2 × 1.3 mm thrombus was situated at the proximal side of the left upper pulmonary vein and calcification of the left anterior descending artery | Warfarin | |
| Wu et al., 2012 [ | 30 M | Hypertension | Chest pain | CT chest PE protocol: multifocal consolidation and ground‐glass opacities in the left lower lobe, left‐sided effusion, well‐defined filling defect, and occlusion within a left inferior pulmonary vein and homogenous hypodense attenuation in the left atrium after contrast administration |
Thrombophilia workup (antithrombin III, protein C/S): negative Tumour markers (CEA, AFP, CA19‐9, CA‐125, NSE): negative TEE: 2 cm diameter filling defects in the left atrium suggestive of thrombus | Unknown |
| Takeuchi, 2013 [ | 73 M | Hyperlipidaemia, asthma | Chest pain | 64‐MDCT: no coronary artery stenosis. Thrombus in the left upper pulmonary vein |
CXR: normal
Protein S activity: 96% Protein C activity: 131% | Dabigatran 150 mg q12 h |
| Takeuchi, 2013 [ | 70 M | Coronary artery disease | Chest pain | 64‐MDCT: large thrombi in the left lower pulmonary vein expanding into the left atrium |
CXR: normal TTE: thrombus in the left atrium 30.2 mm × 8.1 mm, no thrombus in left atrial appendage | Aspirin 100 mg |
| Takeuchi, 2014 [ | 68, M | Hypertension, hyperlipidaemia, stroke | Chest pain | 64‐MDCT: calcification of the coronary arteries. A thrombus in the right lower pulmonary vein |
CXR: normal
Protein S activity: 66% Protein C activity: 155% | Dabigatran |
| Takeuchi, 2015 [ | 82 M | Hypertension, hyperlipidaemia | Chest pain | 64‐MDCT: thrombus in the right lower pulmonary vein |
Protein S activity: 85% Protein C activity: 107% | Dabigatran |
| Rana et al., 2016 [ | 63 M | None | Chest pain | CTPA: no pulmonary embolism. Thrombus in the pulmonary vein extending into the left atrium |
CXR: normal
TTE: normal TEE: confirmed PVT. Pulmonary artery systolic pressure 28 mmHg Thrombophilia workup: normal Tumour markers (AFP, beta‐2 microglobulin, CA 19‐9, PSA): normal | Low‐molecular weight heparin bridged to warfarin |
| Patel et al., 2017 [ | 77 F | Carcinoid tumour s/p resection, hypertension, hyperlipidaemia | Acute shortness of breath | CTA chest: no pulmonary embolism. Non‐exclusive thrombus in the inferior |
TTE: positive McConnell's sign Thrombophilia workup (factor V Leiden, protein C/S): normal Lower extremity duplex US: normal | Rivaroxaban |
| Barreiro et al., 2018 [ | 26 F | Gravida 5 para 5 | Chest pain | CTA chest: right hilar mass or lymph node causing encasement of the right main pulmonary artery and infiltrates in the right middle and lower lobes, consistent with PVT |
CXR: bilateral infiltrations in lower lobes in an interstitial pattern ANA, lupus anticoagulant, and C‐ANCA: negative P‐ANCA: elevated | Oral anticoagulant |
| Ngo, 2021 (current case) | 53 F | Right breast cancer in remission, varicose veins | Chest pain, shortness of breath | CTPA: significant thrombosis of the right lower lobe segmental pulmonary vein |
CXR: normal
Anti‐cardiolipin, lupus anticoagulant, protein C/S: normal | Apixaban |
AFP, alpha‐fetoprotein; ANA, antinuclear antibody; C‐ANCA, antineutrophil cytoplasmic antibodies; CABG, coronary artery bypass graft; CAD, coronary artery disease; CEA, carcinoembryonic antigen; CT, computed tomography; CTA, computed tomography angiography; CTPA, computed tomography pulmonary angiogram; CXR, chest X‐ray; ECG, electrocardiogram; MDCT, multidetector computed tomography; MRI, magnetic resonance imaging; NSE, neuron‐specific enolase; P‐ANCA, perinuclear anti‐neutrophil cytoplasmic antibodies; PE, pulmonary embolism; PSA, prostate‐specific antigen; PVT, pulmonary vein thrombosis; s/p, status post; TTE, transthoracic echo; US, ultrasound.